A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk

Eitemau Tebyg

• A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
  gan: Bethel, M, et al.
  Cyhoeddwyd: (2013)
• Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
  gan: Califf, R, et al.
  Cyhoeddwyd: (2008)
• Updated risk factors should be used to predict development of diabetes.
  gan: Bethel, M, et al.
  Cyhoeddwyd: (2017)
• Prediabetes and the risk of diabetes.
  gan: McMurray, J, et al.
  Cyhoeddwyd: (2012)
• High Frequency of Unrecognized Diabetes in Cardiovascular Patients: Should All Have an Oral Glucose Tolerance Test?
  gan: Bethel, M, et al.
  Cyhoeddwyd: (2008)